Antimicrobial Stewardship: Where We’ve Come and Where We’re Going, An Issue of Infectious Disease Clinics of North America, 1st Edition
Author :
Edited by Emily Sydnor Spivak, MD, MHS, FIDSA and Sage B. Greenlee, PharmD, BCIDP
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout
...view more
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field.
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field.
Key Features
Contains 12 practice-oriented topics including antimicrobial stewardship and pandemic preparedness: lessons learned from COVID-19; health equity considerations; antimicrobial stewardship at transitions of care; antimicrobial stewardship in immunocompromised populations; health system and tele-antimicrobial stewardship: the role of building networks; and more.
Provides in-depth clinical reviews on antimicrobial stewardship, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Emily Sydnor Spivak, MD, MHS, FIDSA, Associate Professor of Medicine, Division of Infectious Diseases, University of Utah School of Medicine ,Medical Director, Antimicrobial, Stewardship Programs, University of Utah Hospital and VA Salt Lake City Health Care System and Sage B. Greenlee, PharmD, BCIDP, Clinical Pharmacist-Antimicrobial Stewardship,University of Utah Health, Department of Pharmacy
Edited by Emily Sydnor Spivak, MD, MHS, FIDSA, Associate Professor of Medicine, Division of Infectious Diseases, University of Utah School of Medicine ,Medical Director, Antimicrobial, Stewardship Programs, University of Utah Hospital and VA Salt Lake City Health Care System and Sage B. Greenlee, PharmD, BCIDP, Clinical Pharmacist-Antimicrobial Stewardship,University of Utah Health, Department of Pharmacy
Antibiotic Stewardship: A Decade of Progress Antimicrobial Stewardship and Pandemic Preparedness: Harnessing Lessons Learned to Advance Our Mission Principles and Practice of Antimicrobial Stewardship Program Resource Allocation Demographic and Geographic Inequities in Antimicrobial Use and Prescribing Behavioral Strategies in Diagnostic Stewardship Next Steps in Ambulatory Stewardship Antimicrobial Stewardship at Transitions of Care Penicillin Allergy Impact and Management Antimicrobial Stewardship in Immunocompromised Patients: Current State and Future Opportunities Development of Inpatient Stewardship Metrics: Is It Time for Public Reporting? Health System and Tele-Antimicrobial Stewardship: The Role of Building Networks What Is Left to Tackle in Inpatient Antimicrobial Stewardship Practice and Research
https://www.asia.elsevierhealth.com/antimicrobial-stewardship-where-weve-come-and-where-were-going-an-issue-of-infectious-disease-clinics-of-north-america-9780443130830.html304722Antimicrobial Stewardship: Where We’ve Come and Where We’re Going, An Issue of Infectious Disease Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780443130830_1.jpg81.74108.99USDInStock/Medicine & Surgery/Infectious Disease/Medicine/Infectious Disease/Clinics/Clinics/Clinics/Medicine/Infectious Disease/Japan Titles43351465054623505466643887255255041525986052631601418269243350884886536505455351451205259833In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field. In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field. 00add-to-cart97804431308302023ProfessionalEdited by Emily Sydnor Spivak, MD, MHS, FIDSA and Sage B. Greenlee, PharmD, BCIDP20231Book152w x 229h (6.00" x 9.00")Elsevier240Oct 27, 2023IN STOCKEdited by <STRONG>Emily Sydnor Spivak</STRONG>, MD, MHS, FIDSA, Associate Professor of Medicine, Division of Infectious Diseases, University of Utah School of Medicine ,Medical Director, Antimicrobial, Stewardship Programs, University of Utah Hospital and VA Salt Lake City Health Care System and <STRONG>Sage B. Greenlee</STRONG>, PharmD, BCIDP, Clinical Pharmacist-Antimicrobial Stewardship,University of Utah Health, Department of PharmacyClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
